<--- Back to Details
First PageDocument Content
Immunosuppressive drug / Tacrolimus / Sirolimus / Immunosuppression / Lung transplantation / Mycophenolic acid / Azathioprine / Anti-thymocyte globulin / Basiliximab / Medicine / Immunosuppressants / Transplant rejection
Date: 2015-04-08 11:59:29
Immunosuppressive drug
Tacrolimus
Sirolimus
Immunosuppression
Lung transplantation
Mycophenolic acid
Azathioprine
Anti-thymocyte globulin
Basiliximab
Medicine
Immunosuppressants
Transplant rejection

https://portal.unos.org/tiedinet/trr.aspx?orgty=hl&wk=true&wksh

Add to Reading List

Source URL: transplantpro.org

Download Document from Source Website

File Size: 73,18 KB

Share Document on Facebook

Similar Documents

Oragnic Cellular Abstract

Oragnic Cellular Abstract

DocID: 1qFEH - View Document

Purines / Medicine / Clinical medicine / Azathioprine / Mercaptopurine / Inflammatory bowel disease / Thiopurine / Immunosuppressive drug / Allopurinol / Tioguanine / Management of ulcerative colitis

AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in

DocID: 1qAnH - View Document

------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

DocID: 1m0Le - View Document

In renal transplant patients at high-immunologic risk •	 Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten

In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten

DocID: 1lhSD - View Document

NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE | VOLUME 24 | NUMMER 05 | meiSamenvatting Azathioprine wordt regelmatig voorgeschreven als tweede keuze oraal immunosuppressivum bij de behandeling van erns

NEDERLANDS TIJDSCHRIFT VOOR DERMATOLOGIE EN VENEREOLOGIE | VOLUME 24 | NUMMER 05 | meiSamenvatting Azathioprine wordt regelmatig voorgeschreven als tweede keuze oraal immunosuppressivum bij de behandeling van erns

DocID: 1dYbe - View Document